7-2541352-C-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_152743.4(BRAT1):​c.1267G>C​(p.Val423Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000023 in 1,605,564 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V423I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00015 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0000096 ( 1 hom. )

Consequence

BRAT1
NM_152743.4 missense

Scores

1
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.318

Publications

4 publications found
Variant links:
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]
BRAT1 Gene-Disease associations (from GenCC):
  • neonatal-onset encephalopathy with rigidity and seizures
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with cerebellar atrophy and with or without seizures
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.04894498).
BP6
Variant 7-2541352-C-G is Benign according to our data. Variant chr7-2541352-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 650361.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152743.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAT1
NM_152743.4
MANE Select
c.1267G>Cp.Val423Leu
missense
Exon 9 of 14NP_689956.2
BRAT1
NM_001350626.2
c.1267G>Cp.Val423Leu
missense
Exon 9 of 14NP_001337555.1
BRAT1
NM_001350627.2
c.742G>Cp.Val248Leu
missense
Exon 8 of 13NP_001337556.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRAT1
ENST00000340611.9
TSL:1 MANE Select
c.1267G>Cp.Val423Leu
missense
Exon 9 of 14ENSP00000339637.4
BRAT1
ENST00000467558.5
TSL:5
n.1549G>C
non_coding_transcript_exon
Exon 7 of 10
BRAT1
ENST00000469750.5
TSL:2
n.2749G>C
non_coding_transcript_exon
Exon 7 of 11

Frequencies

GnomAD3 genomes
AF:
0.000151
AC:
23
AN:
152188
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000298
AC:
7
AN:
235074
AF XY:
0.00000770
show subpopulations
Gnomad AFR exome
AF:
0.000411
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000936
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000963
AC:
14
AN:
1453376
Hom.:
1
Cov.:
33
AF XY:
0.00000415
AC XY:
3
AN XY:
723330
show subpopulations
African (AFR)
AF:
0.000389
AC:
13
AN:
33444
American (AMR)
AF:
0.00
AC:
0
AN:
44472
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26062
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39662
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86130
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
46258
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5754
European-Non Finnish (NFE)
AF:
9.00e-7
AC:
1
AN:
1111392
Other (OTH)
AF:
0.00
AC:
0
AN:
60202
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000151
AC:
23
AN:
152188
Hom.:
1
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.000555
AC:
23
AN:
41444
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000178
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000415
AC:
5
EpiCase
AF:
0.00
EpiControl
AF:
0.0000594

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Sep 03, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1267G>C (p.V423L) alteration is located in exon 9 (coding exon 8) of the BRAT1 gene. This alteration results from a G to C substitution at nucleotide position 1267, causing the valine (V) at amino acid position 423 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Neonatal-onset encephalopathy with rigidity and seizures Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
5.5
DANN
Benign
0.86
DEOGEN2
Benign
0.0035
T
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.83
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.59
T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.049
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L
PhyloP100
0.32
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-0.38
N
REVEL
Benign
0.012
Sift
Benign
0.38
T
Sift4G
Benign
0.85
T
Polyphen
0.14
B
Vest4
0.15
MVP
0.48
MPC
0.046
ClinPred
0.015
T
GERP RS
2.0
Varity_R
0.022
gMVP
0.14
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141807337; hg19: chr7-2580986; API